Posted on August 20, 2018
In August 2018, Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., were appointed as adjunct investigators in the DCEG Epidemiology and Biostatistics Program. Dr. Lowy is the NCI Deputy Director and Chief of the Laboratory of Cellular Oncology in the NCI Center for Cancer Research (CCR), and Dr. Schiller is the Deputy Chief and Head of the Neoplastic Disease Section of the Laboratory of Cellular Oncology in CCR.
Drs. Lowy and Schiller are internationally-acclaimed experts on human papillomavirus (HPV) and were responsible for the initial development, characterization, and clinical testing of the preventive virus-like particle that is now used in three FDA-approved HPV vaccines.
Both are long-time collaborators and mentors to DCEG scientists who are involved in etiologic and translational research related to HPV. As adjunct investigators, they will continue to build on these relationships and contribute to numerous complex HPV-related projects in DCEG.